35 results about "Chronic insufficiency" patented technology

Endovascular prostheses are disclosed that are configured to repair a native venous valve having improper or non-existent valve leaflet coaptation caused by vessel weakness and / or distention. The prostheses are configured to be implanted in the venous system immediately downstream of the malfunctioning valve and act as repair devices to restore proper function to the venous valve by reconfiguring and supporting the valve leaflets and thereby improving their coaptation.

The invention discloses a medicine for treating chronic renal insufficiency and chronic renal failure diseases. The medicine comprises the following raw materials in parts by weight: 70-90 parts of hairy antler, 17-23 parts of prepared common monkshood daughter root, 70-90 parts of cassia twig and 170-230 parts of all-grass of desertliving cistanche; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of common macrocarpium fruit, 85-115 parts of prepared rhizome of rehmannia, 170-230 parts of largehead atractylodes rhizome, 170-230 parts of Chinese angelica and 45-55 parts of astragalus membranaceus; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of Indian buead, 170-230 parts of plantain seed and 17-23 parts of root-bark of tree peony; and preferably, the medicine also comprises the following raw materials in parts by weight: 85-115 parts of twotooth achyranthes root and 45-55 parts of rheum rhabarbarum. The medicine disclosed by the invention can be used for tonifying the kidney-qi, strengthening the kidney-yang and recovering the renal functions, and can be used for treating chronic renal insufficiency, chronic renal failure, limb weakness, waist-knee-limb coldness, difficult urination, frequent urination or nighttime micturition, bleak or dark complexion, sluggish in facial expression, double-limb pitting edema, face and eye edema, urea nitrogen increase, creatinine increase, hypertensive nephropathy and diabetic nephropathy caused by insufficiency of kidney-yang, and treating the chronic renal insufficiency and chronic renal failure diseases caused by medicine injury or other reasons.

The invention is related to the use of a Chinese medicine composition serving for preparing drug for curing chronic cardiac insufficiency. The composition is formed of the following raw materials by weight: 22.2% to 66.8% of astragalus, 11.6% to 33.4% of salvia, 2.5% to 13.5% of panax notoginseng, 14.5% to 44.3% of lignum dalbergiae odoriferae.

An application of the pueraria flavone in preparing the medicines for treating chronic cerebral ischemia is disclosed. Its preparing process includes such steps as providing pueraris roots, extracting in water or alcohol, concentrating, depositing in alcohol, purifying by chromatography, eluting and spray drying.

An application of the medicinal composition composed of 13 Chinese-medicinal materials including notopterygium root, Chuan-xiong rhizome, peach kernel, safflower, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Endovascular prostheses are disclosed that are configured to repair a native venous valve having improper or non-existent valve leaflet coaptation caused by vessel weakness and / or distention. The prostheses are configured to be implanted in the venous system immediately downstream of the malfunctioning valve and act as repair devices to restore proper function to the venous valve by reconfiguring and supporting the valve leaflets and thereby improving their coaptation.

An application of the medicinal composition composed of 18 Chinese-medicinal materials including Chinese angelica root, astragalus root, red peony root, Chuan-xiong rhizome, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The present invention discloses a Chinese medicine for curing chronic nephritis and chronic renal insufficiency with obvious therapeutic effect and small size effect. Said invention is made up by using 7 Chinese medicinal materials of centella, cornus fruit, ligusticum root, astragalus root, salvia root and others.

An application of the gingko leaf's extract (pueraria flavone) in preparing the medicine for treating chronic cerebral ischemia is disclosed. A process for preparing said pueraria flavone is also disclosed.

An application of the medicinal composition composed of Chuan-xiong rhizome, pueraria root and puncturevine caltrop in preparing the medicine for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of auxiliary choerosponidas fruit, red sage root, cloves, borneol, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

A Chinese medicine for treating chronic renal insufficiency is prepared from 14 Chinese-medicinal materials including red sage root, astragalus root, red peony root, rhubarb, etc through respectively pre-treating and proportional dispensing.

An application of the medicinal composition composed of corydalis tube, northern siphonostegia, fortume's drynaria rhizome and ginseng in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention provides a traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy. The traditional Chinese medicine clysis fluid is prepared from the following Chinese herbs: 100g of prepared rhubarb, 100g of dragon's bone, 100g of oyster, 75g of dandelion, 50g of processed radix aconiti lateralis, 50g of cinnamon, 50g of cassia twig, 50g of szechuan lovage rhizome, 50g of safflower, 50g of poria cocos, 50g of agaric, 50g of rose, 50g of hawthorn, 50g of notoginseng powder, 50g of hairyvein agrimonia herband bud, 50g of corydalis tuber, 50g of peach kernel, 50g of root of bidentate achyranthes, suberect spatholobus stem, 50g of dragon's blood, 25g of frankincense, 25g of myrrh, 50g of root of doubleteeth pubescent angelica, 50g of incised notopterygium, 50g of Chinese rose flower, 50g of India mustard seed, 50g of amber powder, 50g of yam rhizome, 50g of thinleaf milkwort root-bark, 50g of silktree albizzia bark, 50g of gecko, 100g of Chinese yam, 75g of manyprickle acanthopanax root, 50g of medicinal Indian mulberry, 50g of walnut kernel, 50g of songaria cynomorium herb, 50g of tuber fleeceflower root, 50g of Chinese angelica, 100g of tortoise shell, 100g of turtle shell, 50g of malaytea scurfpea fruit and 100g of black chicken bone. The traditional Chinese medicine clysis fluid has the effects of activating blood to dissipate stasis, relieving swelling and pain, eliminating cold to stop pain, clearing damp and promoting diuresis and the like, is capable of effectively covering the shortage that the conventional treatment by use of single western medicine is high in side effect and fails in correcting the yang deficiency-induced cold symptom, and is short in course of treatment and low in side effect.

The invention discloses a medicine for treating chronic renal insufficiency and chronic renal failure diseases. The medicine comprises the following raw materials in parts by weight: 70-90 parts of hairy antler, 17-23 parts of prepared common monkshood daughter root, 70-90 parts of cassia twig and 170-230 parts of all-grass of desertliving cistanche; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of common macrocarpium fruit, 85-115 parts of prepared rhizome of rehmannia, 170-230 parts of largehead atractylodes rhizome, 170-230 parts of Chinese angelica and 45-55 parts of astragalus membranaceus; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of Indian buead, 170-230 parts of plantain seed and 17-23 parts of root-bark of tree peony; and preferably, the medicine also comprises the following raw materials in parts by weight: 85-115 parts of twotooth achyranthes root and 45-55 parts of rheum rhabarbarum. The medicine disclosed by the invention can be used for tonifying the kidney-qi, strengthening the kidney-yang and recovering the renal functions, and can be used for treating chronic renal insufficiency, chronic renal failure, limb weakness, waist-knee-limb coldness, difficult urination, frequent urination or nighttime micturition, bleak or dark complexion, sluggish in facial expression, double-limb pitting edema, face and eye edema, urea nitrogen increase, creatinine increase, hypertensive nephropathy and diabetic nephropathy caused by insufficiency of kidney-yang, and treating the chronic renal insufficiency and chronic renal failure diseases caused by medicine injury or other reasons.

An application of the medicinal composition composed of ginseng and white peony root in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention relates to a medicine, in particular to a Mongolian medicine for treating nephritis and renal insufficiency. The medicine comprises the following raw medicines in part by weight: 4 to 6 parts of areca catechu, 2 to 4 parts of amomum cardamomum, 1 to 3 parts of white sal ammoniac, 0.5 to 1.5 parts of golden myrobalan and 0.8 to 1.2 parts of cordyceps sinensis. The medicine has the benefits that the curative effect on nephritis is obvious, the effects of enhancing, protecting and maintaining renal function are facilitated, the treatment course is short, the effect is quick, no toxic or side effect exists, material drawing is easy, the preparation is simple, the cost is low, the use is convenient, and the application range is wide, so that the medicine has a relatively high use value and a broad market prospect.

A method and device that addresses the problem of an incompetent aortic valve by using a simple cardioplegia catheter that can deliver cardioplegia solution to the coronary arteries through the usual aortic cannulation site even in the presence of aortic valve incompetence. The device includes a cardioplegia cannula (32) with an additional lumen containing a nitinol wire (34) inside it that allows advancement of a folded nitinol umbrella (36) with a non-porous membrane or a compressed nitinol ring that covers the aortic valve when opened. During installation, after puncture of the aorta by the coaxial needle and removal of the coaxial needle but before installation of the cardioplegia solution through the central lumen of the catheter, the nitinol umbrella (in folded position) or nitinol ring (in compressed position) is advanced through the second lumen into the aorta just above the aortic valve. The nitinol umbrella is unfolded using the nitinol wire to expose the inverted umbrella configuration with attached membrane and is then advanced as a unit with the cardioplegia catheter until the nitinol umbrella covers the aortic valve at its deployed position.

An application of the medical composition composed of red sage root, notoginseng and dalbergia wool oil in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The present invention relates to a medicine in treating coronary heart disease or coronary heart disease with complication of cardiac functional insufficiency. It is characterized by that it made rhodiola kirilowii and notoginseng as raw material, red peony root and ginkgo leaf also can also be added. Said invention also discloses its preparation method.

An application of the medicinal composition composed of Naoyiqin, the extract of notoginseng, VB6 and VE in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medical composition composed of red sage root, gingko leaf, gynostemma pentaphyllum and argyi leaf in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention discloses a medicine for treating renal insufficiency, which relates to the technical field of medicines, and solves the treatment problem of renal insufficiency. The medicine is mainlyprepared by combining the following traditional Chinese medicines in parts by weight: 15 parts of radix bupleuri, 15 parts of herba cistanche, 20 parts of Chinese yams, 15 parts of semen cuscutae, 15parts of mulberry fruit, 12 parts of cortex moutan, 15 parts of angelica sinensis, 15 parts of stiff silkworm, 10 parts of lycium barbarum, 15 parts of cowherb seeds, 15 parts of calcined oyster shell, 10 parts of seaweeds, 10 parts of kelps and 7 parts of liquorice.

The invention relates to a medicament for treating chronic cardiac insufficiency. The medicament is prepared from the following substances in proportions by weight: red peony root, peach kernel, white hyacinth bean, smilax china, pinellia ternata, peucedanum decursivum maxim, kapok, tuber fleeceflower stem, yam, manchurian lilac bark, sea-tangle, thlaspi arvense l, pericarpium citri reticulatae viride, spina date seed, folium sauropi, hooker winghead root, golden cypress, witloof, bighead atractylodes rhizome, dandelion, retinervus luffae fructus, semen celosiae, carthamus tinctorious, prepared rehmannia root, rhizoma dioscoreae septemlobae xerxes, orange peel, beautiful sweetgum fruit, perfoliote knotweed herb, fructus broussonetiae, common gendarussa herb, paeonia suffruticosa, angelica sinensis, rhizoma nelumbinis, herba siegesbeckiae, medulla stachyuri, fructus gardeniae, pericarpium citri reticulatae, radix bupleuri, Chinese mahonia stem, piper cubeba, concha arcae, poria cocos, cassia twig, rhizoma cyperi, spatholobus suberctu and citron. The medicament for treating the chronic cardiac insufficiency is prepared from all natural medicines, is definite in curative effect, can be used for effectively treating the chronic cardiac insufficiency, thereby being very suitable for clinical promotion.

The invention discloses a pharmaceutical preparation for treating progressive muscular atrophy, cerebral hemorrhage sequelae and cardiac insufficiency, and a preparation method thereof. The pharmaceutical preparation for treating progressive muscular atrophy, cerebral hemorrhage sequelae and cardiac insufficiency is prepared from the following components in parts by weight: 100 parts of adenosine disodium triphosphate, 200-400 parts of sodium alginate, 100-200 parts of hydroxypropyl methylcellulose, 400-800 parts of glucan, 50-200 parts of sodium carboxymethyl starch, 50-100 parts of sodium dodecyl sulfate, 15-30 parts of a micropowder silica gel and 15-30 parts of magnesium stearate. According to the preparation method disclosed by the invention, the adenosine disodium triphosphate is prepared into an inclusion compound by a sodium alginate swelling technique, and then the main drug inclusion compound is further prepared into dispersible tablets. The adenosine disodium triphosphate in the product disclosed by the invention has increased dissolubility, higher dissolution rate, shortened disintegration time limited and improved bioavailability, thereby improving the curative effect, and the preparation method has simple process, low production cost, low energy consumption and easy implementation of industrialized production.

A medicine for acute or chronic cardiac disfunction is disclosed. Its advantages are high natural level and safety and low toxic by-effect.

An application of the medicinal composition composed of ginseng and white peony root in preparing the medicines for treating chronic cerebral ischemia is disclosed.